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A B S T R A C T
Background: Neuroticism is a risk factor for selected mental and physical illnesses and is inversely
associated with intelligence. Intelligence appears to interact with neuroticism and mitigate its
detrimental effects on physical health and mortality. However, the inter-relationships of neuroticism
and intelligence for major depressive disorder (MDD) and psychological distress has not been well
examined.
Methods: Associations and interactions between neuroticism and general intelligence (g) on MDD, self-
reported depression, and psychological distress were examined in two population-based cohorts:
Generation Scotland: Scottish Family Health Study (GS:SFHS, n = 19,200) and UK Biobank (n = 90,529).
The Eysenck Personality Scale Short Form-Revised measured neuroticism and g was extracted from
multiple cognitive ability tests in each cohort. Family structure was adjusted for in GS:SFHS.
Results: Neuroticism was strongly associated with increased risk for depression and higher psychological
distress in both samples. Although intelligence conferred no consistent independent effects on
depression, it did increase the risk for depression across samples once neuroticism was adjusted for.
Results suggest that higher intelligence may ameliorate the association between neuroticism and self-
reported depression although no significant interaction was found for clinical MDD. Intelligence was
inversely associated with psychological distress across cohorts. A small interaction was found across
samples such that lower psychological distress associates with higher intelligence and lower
neuroticism, although effect sizes were small.
Conclusions: From two large cohort studies, our findings suggest intelligence acts a protective factor in
mitigating the effects of neuroticism on psychological distress. Intelligence does not confer protection
against diagnosis of depression in those high in neuroticism.
C 2017 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents lists available at ScienceDirect
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251. Introduction
Major depressive disorder (MDD) is a leading cause of disease
burden worldwide [1]. Although MDD aetiology remains elusive, a26
27
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nd/4.0/).large proportion of its genetic covariance is attributable to
neuroticism [2,3], suggesting a causal relationship. Neuroticism is
a partially-heritable personality trait representing high emotionali-
ty and stress sensitivity [4], which correlates highly with MDD
[5]. Cross-sectional studies suggest a strong positive association
between neuroticism and MDD [6–8], whilst higher neuroticism
prospectively associates with depression longitudinally [2,9–12],
even when controlling for overlapping criteria [13–15] andneuroticism in relation to depression and psychological distress:
017), http://dx.doi.org/10.1016/j.eurpsy.2016.12.012
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EURPSY 3459 1–8mographics [16,17]. Whist the public health impacts of neuroti-
sm are wide-ranging (for a comprehensive review see Lahey),
uroticism may be an indirect measure of later MDD risk, rather
an the causative risk factor itself. Whilst MDD is often recurrent
8], neuroticism is a stable trait [19] suggesting that their
rrelation is unlikely to be substantially attributable to an effect
 MDD on neuroticism.
General intelligence (g) is a latent construct theorized to explain
e common observation that people who excel in one type of
gnitive task tend to excel in others [20]. When reduced to a
gle factor (g) these correlations explain approximately 50% of
e covariance between tests. Lower intelligence in early life has
en found to be a risk factor for poor physical health [21] and
rly mortality in adulthood [22,23]. Although research specifical-
 regarding MDD is relatively sparse [24], there is evidence to
ggest that g is impaired in depression [25,26] with longitudinal
udies suggesting lower g in childhood or adolescence confers
lnerability to psychopathology in adulthood [27–30].
Psychological distress represents a cluster of emotional
mptoms linked to depression [31–33]. Although symptoms of
stress are common in population samples [34,35], they indicate
ly subthreshold mental health problems. With self-report
easures of distress [36,37] freely available in epidemiological
search, their measurement provides greater detective power to
ake distinctions between syndrome and subthreshold symp-
ms. Longitudinal research suggests neuroticism has a strong,
rect effect on psychological distress [38]. Low childhood
telligence strongly associates with increased psychological
stress in adulthood [27,39], which may precede MDD onset
0]. However, this is not a universal observation, particularly in
udies accounting for socioeconomic status (SES).
Intelligence and neuroticism may interact to influence indices
 health. A longitudinal study of war veterans [41] found high
uroticism and low cognitive ability were separate risk factors for
ortality. Specifically, a 1-standard deviation increase in neuroti-
sm resulted in a 33% increase in mortality; a 1-standard deviation
crease in intelligence associated with a 27% increase in
ortality. An interaction (hazards ratio of 0.89) suggested that
gh neuroticism with low cognitive ability associates with high
k of poor health and reduced lifespan. Furthermore, high
gnitive ability moderates the adverse effects of neuroticism on
justment [42]. Whether similar interactions exist with regard to
eir effects on depression remains unknown. No investigation has
t examined how intelligence and neuroticism influence risk for
DD and how they may moderate each other’s associations inble 1
mographic, clinical, and cognitive characteristics of GS:SFHS and UK Biobank indiv
GS:SFHS 
Total
(n = 19,200)
Control
(n = 16,719)
ge 47.16 (14.97) 47.23 (15.27) 
ex (% female) 59 57 
euroticism 3.84 (3.16) 3.45 (2.94) 
HQ score 15.93 (8.81) 14.93 (7.56) 
HQ score – – 
echsler Digit Symbol Substitution Task 72.31 (17.09) 72.45 (17.23) 
ill-Hill Vocabulary Test 30.06 (4.76) 30.05 (4.75) 
eschler Logical Memory Test I & II 31.01 (8.04) 30.99 (8.09) 
erbal Fluency Test 25.68 (8.10) 25.60 (8.11) 
eaction time – – 
isual memory – – 
erbal-numerical reasoning – – 
IMD 3903.82 (1851.91) 3957.58 (1832.28
ownsend Score – – 
:SFHS: Generation Scotland: the Scottish Family Health Study; MDD: Major Depressi
D: the Scottish Index of Multiple Deprivation. With the exception of sex, values r
Significantly different from controls at P < 0.05.
Please cite this article in press as: Navrady LB, et al. Intelligence and
Evidence from two large population cohorts. European Psychiatry depression and psychological distress. Such an analysis may serve
to clarify the mechanisms underlying MDD.
In this study, two large population-based cohorts were
examined – Generation Scotland: Scottish Family Health Study
(GS: SFHS) [43,44] and UK Biobank [45,46]. As previous studies
suggest strong associations of neuroticism with risk of MDD [2,5],
the same effect was hypothesised here. We hypothesised that
higher intelligence may reduce MDD risk by mitigating the adverse
effects of neuroticism, similarly to the interaction identified for
mortality [41]. This reasoning transfers to psychological distress,
hypothesising a positive association between neuroticism and
psychological distress would be ameliorated by higher intelligence.
2. Method
2.1. GS:SFHS Overview
GS:SFHS is a family and population-based cohort recruited
throughout Scotland between 2006 and 2011 [43]. During clinic
assessment, participants aged 18–98 (n = 24,084) provided clinical,
cognitive and biological data. Full details are provided elsewhere
[43,44]. The GS:SFHS sample is predominately female (59%), and
generally healthier and wealthier than the Scottish population
[43]. This study includes 19,200 individuals with complete data of
interest. Demographic information from this cohort is provided in
Table 1 and within the Supplementary materials.
Study assessments: during clinic assessment, participants were
screened for lifetime history of MDD using a structured clinical
interview [47]. Diagnosis of MDD follows DSM-IV criteria; if either
symptoms of depressive mood or anhedonia are endorsed, a
minimum of four further symptoms must also be endorsed. Clinical
significance must be endorsed, too (ie., symptoms lasting nearly all
day, every day for a minimum of two weeks). This study includes
2481 individuals meeting criteria for lifetime history of MDD
(13%), and 16,719 non-MDD cases (87%).
Four cognitive tests measuring intelligence were administered
during clinic assessment [43,44]. The Wechsler Digit Symbol
Substitution Task [48] measured processing speed. One paragraph
from The Weschler Logical Memory Test I & II [49] measured verbal
declarative memory. The Verbal Fluency Test measured executive
function [48] using phonemic lists of C, F and L. Vocabulary was
measured with The Mill-Hill Vocabulary Test [50], using combined
junior and senior synonyms. General intelligence (g) was extracted
from these tests, as the first un-rotated principal component [51],
explaining 41% of the variance. Loadings for processing speed,iduals in the current study.
UK Biobank
Lifetime MDD
(n = 2481)
Total
(n = 90,529)
Control
(n = 60,402)
Lifetime MDD
(n = 30,127)
46.39 (12.89)* 56.64 (8.13) 57.15 (8.16) 55.60 (7.98)*
72* 52 46 65*
6.45 (3.32)* 3.46 (2.86) 2.65 (2.43) 5.09 (2.96)*
22.70 (12.77)* – – –
– 1.36 (1.91) 0.89 (1.33) 2.30 (2.47)*
71.44 (16.06)* – – –
30.15 (4.84) – – –
31.02 (7.68)* – – –
26.21 (8.05)* – – –
– 564.00 (119.87) 564.70 (119.98) 562.58 (119.66)*
– 4.04 (3.21) 4.04 (3.23) 4.04 (3.17)
– 6.09 (2.14) 6.07 (2.16) 6.12 (2.11)*
) 3541.51 (1941.03)* – – –
– 1.37 (2.84) 1.47 (2.77) 1.06 (2.94)*
ve Disorder; GHQ: General Health Questionnaire; PHQ: Patient Health Questionnaire;
epresent Mean (SD).
 neuroticism in relation to depression and psychological distress:
(2017), http://dx.doi.org/10.1016/j.eurpsy.2016.12.012
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EURPSY 3459 1–8vocabulary, verbal declarative memory and executive function
were 0.57, 0.68, 0.63 and 0.69 respectively.
The self-reported Eysenck Personality Questionnaire Short
Form-Revised (EPQ-SF) [52] measured neuroticism. Twenty-four
questions assessed neuroticism and extraversion, with total scores
on each subscale ranging from 0–12. Higher scores indicate higher
levels of each trait. This scale has been concurrently validated [53]
with high reliability [54].
Psychological distress was self-reported using the General
Health Questionnaire (GHQ-28) [36]. Twenty-eight items were
scored from 0 (‘‘not at all’’) to 3 (‘‘much more than usual’’) with a
total score ranging from 0–84. Higher scores indicate increased
psychological distress.
The Scottish Index of Multiple Deprivation (SIMD) [55] is an
official tool which identifies deprivation by combining different
indicators (eg., income, crime) into a single index. The SIMD
divides Scotland into 6505 small areas based on participant
postcode, and assigns them a relative ranking from 1 (most
deprived) to 6505 (least deprived).
2.2. UK Biobank Overview
UK Biobank is a population cohort recruited across the UK from
2006–2010. During an extensive baseline assessments [56]
participants aged 40–69 (n = 502,682) provided biological, physi-
cal, and touch-screen questionnaire measures of socio-demogra-
phics (e.g., age, sex), psychosocial factors (e.g., mental health), and
cognitive function. UK Biobank represents a wide range of
exposures typical within the UK population [57], and has been
described in detail elsewhere [45,46]. In this study, 147 individuals
were removed from analysis due to participation in GS:SFHS. In
total, 90,529 individuals with complete data of interest were
included. Demographic information is provided in Table 1 and in
the Supplementary materials.
Study assessments: between 2008–2010, a touch-screen
questionnaire was added to the protocol to assess probable
depression (n = 172,751) [58]. Although depression was not
assessed using a precise diagnostic tool, the classification followed
a self-report approach within the guidelines of the ICD- 10 [59] and
the DSM-IV [60]. Lifetime history of depression was assessed using
items relating to the lifetime experience of depressive symptoms
and help-seeking for mental health. A detailed description of how
this phenotype was derived is provided elsewhere [56]. This study
included 30,127 (33%) individuals self-reporting lifetime history of
depression, and 60,402 (67%) non-depressed cases.
Three novel cognitive tests were administered via touch-screen
questionnaire measuring reaction time, verbal-numerical reason-
ing, and visual memory [56]. A timed symbol matching test
measured reaction time as the mean response time in ms over
12 trials; higher reaction times equate to poorer performance.
Thirteen logic/reasoning-type questions assessed verbal-numeri-
cal reasoning - the total number of correct answers given within
two-minutes was analysed. A visuo-spatial memory task measured
the number of errors made when matching card pairs, higher
scores reflect poorer cognitive function. From these tests, g was
extracted as the first un-rotated principal component [51],
explaining 44% of the variance in scores. Loadings onto g were:
0.61 (verbal-numeric reasoning), 0.57 (visual memory), and 0.55
(reaction time).
Neuroticism was assessed using 12 questions from the Eysenck
Personality Questionnaire Short Form-Revised (EPQ-SF) [52],
administered via a touch-screen questionnaire. A total score from
0–12 was produced, with higher scores reflecting increasing
neuroticism.
The first four questions of the Patient Health Questionnaire–9
(PHQ9) [37] were administered by touch-screen questionnaire toPlease cite this article in press as: Navrady LB, et al. Intelligence and 
Evidence from two large population cohorts. European Psychiatry (2measure psychological distress. Responses on a scale from 0 (‘‘Not
at all’’) to 3 (‘‘Nearly every day’’) were aggregated and a higher total
score denoted higher levels of psychological distress.
The Townsend Deprivation Index [61] is a census-based
measure of deprivation, incorporating unemployment, non-car
ownership, non-home ownership and household overcrowding
into a single index. Small geographical areas based on postcode
information are allocated Townsend Scores. Higher scores repre-
sent greater deprivation.
2.3. Statistical analysis
In GS:SFHS, the MCMCglmm package was used. The Markov
Chain Monte Carlo estimator produces generalised linear mixed
models for binary outcomes (using the ‘‘threshold’’ family with a
probit link function). The threshold link is unique to MCMCglmm,
and although produces very similar results to a logit function,
threshold links most closely match the underlying assumptions of
latent normal errors in pedigree-based mixed effect models
[62]. MCMCglmm was essential to control for genetic relatedness
of the sample, which was fitted as a random effect using an inverse
pedigree matrix. Due to limitations within MCMCglmm with
missing predictor variables, only complete data can be used. An
interaction was fitted to estimate the moderating effect of g on the
contribution of neuroticism to MDD. Another model examined this
interaction while conditioning on deprivation. Regression coef-
ficients are reported as Odds-Ratios. In a second set of analyses,
GHQ was modelled as a normally distributed outcome variable.
Neuroticism and GHQ were standardised to have a mean of zero
and a standard deviation of 1. Age (standardised) and sex were
used as fixed effects throughout.
In UK Biobank, generalized linear regression analyses were
conducted as kinship need not be accounted for. The main effects
of neuroticism and g were examined as predictors for self-
reported depression. The interaction between neuroticism and g
on depression was modelled. Another model examined this
interaction while adjusting for deprivation. Generalized linear
regressions were fitted with a logit link function and Odds-Ratios
reported. A second set of analyses examined psychological
distress (PHQ) using linear regression models. Neuroticism and
PHQ were standardised to have a mean of zero and a standard
deviation of one. Reaction time was log transformed due to a
significantly positive skew. Visual memory was transformed
with a log + 1 transformation because it was significantly skewed
and zero-inflated. All regression analyses co-varied for age, and
sex.
3. Results
3.1. GS:SFHS
As seen in Table 1, MDD cases were younger, predominately
female, and had higher GHQ and neuroticism scores. No group
differences were found in general intelligence; (t(3243.38) = 1.39,
P = 0.17, Cohen’s d = 0.03). Group differences were found in
processing speed and executive function. MDD cases were from
less deprived areas; (t(3171.20) = 9.93, P = 2.20  1016, Cohen’s
d = 0.22). Full statistical output can be found in the Supplementary
materials.
3.1.1. Associations of neuroticism and g with MDD status
Higher neuroticism was strongly associated with increased risk
for MDD. A 1SD-increase in neuroticism increased MDD risk by an
odds-ratio of 3.61 (95% CIs = [3.28, 4.01], P < 1.00  104).
Although no age effects were found, being female increased risk
for MDD by an Odds-Ratio of 1.76 (95% CIs = [1.52, 2.03],neuroticism in relation to depression and psychological distress:
017), http://dx.doi.org/10.1016/j.eurpsy.2016.12.012
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EURPSY 3459 1–8< 1.00  104). g had no independent effect on risk for MDD
R = 1.02, 95% CIs = [0.99, 1.07], P = 0.53).
1.2. Interaction between neuroticism and g on MDD
No interaction was found between neuroticism and g
R = 1.03, 95% CI = [0.98, 1.08], P = 0.32), see Fig. 1 and Table 2,
en after co-varying for SIMD. However, the main effect of
uroticism was strongly associated with MDD risk (OR = 3.71,
% CI = [3.37, 4.12], P < 1.00  104) whilst g was associated with
small increase in MDD risk (OR = 1.14, 95% CIs = [1.07, 1.20],
< 1.00  104). A main effect was found whereby higher
privation confers risk for MDD (OR = 0.80, 95% CIs = [0.75,
86], P < 1.00  104).ble 2
sults of a MCMC generalized linear mixed model from GS:SFHS predicting Odds-Ratio
er 95% confidence intervals and the Deviance Information Criterion AND results of
efficients for psychological distress (PHQ), P-value, upper and lower 95% confidenc
ample Outcome Variables Odds-Ratio b Lower 9
S:SFHS MDD Age 1.00 – 0.99 
Sex (F) 1.71 – 1.48 
Neuroticism 3.71 – 3.37 
g 1.14 – 1.07 
Neuroticism*g 1.03 – 0.98 
K Biobank MDD Age 0.98 – 0.99 
Sex (F) 1.34 – 1.32 
Neuroticism 2.40 – 2.36 
g 1.06 – 1.04 
Neuroticism*g 0.96 – 0.95 
S:SFHS GHQ Age – 0.00 0.00 
Sex (F) – 0.04 0.02 
Neuroticism – 0.50 0.49 
g – 0.04 0.05 
Neuroticism*g – 0.05 0.06 
K Biobank PHQ Age – 0.02 0.02 
Sex (F) – 0.02 0.02 
Neuroticism – 0.51 0.51 
g – 0.05 0.06 
Neuroticism*g – 0.02 0.03 
MC: Markov Chain Monte Carlo; GS:SFHS: Generation Scotland: the Scottish Fam
iterion; g: General Intelligence; MDD: major depressive disorder; PHQ: Patient Hea
Please cite this article in press as: Navrady LB, et al. Intelligence and
Evidence from two large population cohorts. European Psychiatry 3.1.3. Associations of neuroticism and g with psychological distress
Neuroticism was associated with increased psychological
distress; a 1SD increase in neuroticism was associated with an
increase in GHQ of b 0.52 (95% CIs = [0.50, 0.53], P < 1.00  104).
A small inverse relationship was found whereby higher g was
associated with decreased levels of psychological distress
(b = 0.08, 95% CIs = [0.09, 0.07], P < 1.00  104).
3.1.4. Interaction between neuroticism and g on psychological distress
A small interaction suggested higher g interacts with neuroti-
cism to mitigate neuroticism’s detrimental association on GHQ
(b = 0.05, 95% CIs = [0.06, 0.04], P < 1.00  104), see Fig. 2 and
Table 2. This interaction remained after co-varying for deprivation.s of MDD status, beta-coefficients for psychological distress (GHQ), P-value, upper and
 a logistic regression from UK Biobank predicting Odds-Ratios for MDD status, beta-
e intervals, the Akaike Information Criterion and adjusted R2 value for the model.
5% CIs Upper 95% CIs P-value DIC AIC R2
1.01 9.71  102 12,561.35 – –
1.97 < 1.00  104
4.12 < 1.00  104
1.20 < 1.00  104
1.08 0.32
0.99 < 2.00  1016 – 98,785 –
1.36 < 2.00  1016
2.44 < 2.00  1016
1.07 5.08  1014
0.98 < 1.09  107
0.00 0.59 47,873.87 – –
0.07 2.63  103
0.52 < 1.00  104
0.03 < 1.00  104
0.04 < 1.00  104
0.01 < 2.00  1016 – – 0.2976
0.01 1.57  108
0.52 < 2.00  1016
0.05 < 2.00  1016
0.02 < 2.00  1016
ily Health Study; GHQ: General Health Questionnaire; DIC: Deviance Information
lth Questionnaire; AIC: Akaike Information Criterion.
 neuroticism in relation to depression and psychological distress:
(2017), http://dx.doi.org/10.1016/j.eurpsy.2016.12.012
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Fig. 2. Psychological distress scores from the interaction of neuroticism and g in both GS:SFHS (GHQ) and UK Biobank. Regression lines reflect the interaction at mean g (black
line) and 2SD above (blue line) and below mean g (pink line).
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As reported in Table 1, MDD cases were younger, predominately
female, and had higher psychological distress (PHQ) and neuroti-
cism scores than non-depressed cases. Significant differences were
found in verbal-numerical reasoning (in which non-depressed
cases performed better) and reaction time (in which depressed
cases performed better). g was higher in depressed cases
(t(61357) = 2.65, P = 8.12  103, Cohen’s d = 0.02). Non-de-
pressed cases had lower deprivation scores than depressed cases;
(t(57110) = 20.08, P = 2.2  1016,Cohen’s d = 0.14), although
this difference was small. See the Supplementary materials for
full statistical output.
3.2.1. Associations of neuroticism and g with MDD status
Higher neuroticism was associated with increased likelihood of
self-reported depression. For every 1SD increase in neuroticism,
the odds for depression increased by 2.39 (95% CIs = [2.35, 2.43],
P < 2.00  1016). No main effects of g were found (OR = 1.00, 95%
CIs = [0.99, 1.01], P = 0.86). Small effects of age and sex were found.
3.2.2. Interaction between neuroticism and g on MDD
A small interaction was found in which high levels of
intelligence and neuroticism associate with reduced self-reported
depression (OR = 0.96, 95% CIs = [0.95, 0.98], P = 1.09  107), see
Table 2 and Fig. 1. This interaction remained after co-varying for
deprivation.
3.2.3. Associations of neuroticism and g with psychological distress
Neuroticism was moderately associated with increased levels
of psychological distress. For every 1SD increase in neuroticism,
PHQ increased by b 0.52 (95% confidence intervals = [0.51, 0.52],
P < 2.00  1016). g was associated with a small reduction in PHQ
(b = 0.08, 95% CIs = [0.08, 0.07], P < 2.00  1016).
3.2.4. Interaction between neuroticism and g on psychological distress
A small interaction was found in which g moderates the
detrimental effects of neuroticism on psychological distress
(b = 0.02, 95% CIs = [0.03, 0.02], P < 2.00  1016), seePlease cite this article in press as: Navrady LB, et al. Intelligence and 
Evidence from two large population cohorts. European Psychiatry (2Table 2 and Fig. 2. This interaction remained after co-varying for
deprivation.
4. Discussion
The cross-sectional associations between neuroticism, general
intelligence (g), MDD, self-reported depression, and psychological
distress were examined in two large population based cohorts;
GS:SFHS and UK Biobank. Neuroticism was strongly associated
with increased risk for both MDD diagnosis and self-reported
depression, replicating previous findings [6,7]. Intelligence con-
ferred no consistent independent effects but associated with an
increased risk for depression once neuroticism was adjusted for.
UK Biobank data suggest an interaction whereby higher g has a
small effect in reducing the impact of neuroticism on self-reported
depression. This interaction was small, both absolutely, and in
comparison to the main effects of neuroticism. No such interaction
was found in GS:SFHS using a clinical measure of MDD. However,
across samples, the risk conferred by neuroticism after co-varying
for g appears to be increased in terms of the absolute OR value
when compared to basic models. Overall, results demonstrate an
association whereby intelligence provides modest protection
against the risk-conferring effects of neuroticism on self-reported
depression, but not clinical MDD.
Consistent and replicable findings were found suggesting
higher neuroticism associates with increased psychological
distress, whereas higher intelligence associates with reduced
psychological distress. A small interaction was found across
samples such that lower distress associates with higher intelli-
gence and lower neuroticism. Although these results are of small
magnitude, they suggest an important interaction whereby higher
g lessens the strength of the neuroticism-distress association.
This is the first study of intelligence’s potential protective
influence on MDD [63], self-reported depression, and psychologi-
cal distress in high neuroticism individuals. Consistent with
previous research the strong link between neuroticism with
increased risk for depression and psychological distress was
replicated with moderate effect sizes. Although longitudinal work
suggests intelligence provides protection to mental healthneuroticism in relation to depression and psychological distress:
017), http://dx.doi.org/10.1016/j.eurpsy.2016.12.012
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EURPSY 3459 1–84,28,29], we found g increased the risk for depression when
justed for neuroticism. The magnitude of this risk was very
all, however. Across cohorts, intelligence associated with
creased levels of psychological distress. A modest association
 intelligence as a mitigating factor in reducing psychological
stress in individuals with high neuroticism was found in both
horts. Although this study suggests intelligence provides a
otective function in self-reported depression and psychological
stress (which mirrors previous research [23,41,42]), intelligence
as not found to be protective against diagnosis of depression in
ose high in neuroticism.
It is unclear why intelligence associates with protection to risk
r psychological distress, but not MDD. One supposition is that
dividuals with higher intelligence may be more likely to seek
lp, and therefore are more likely to receive a clinical diagnosis of
pression. Another postulation could be that intelligence has an
fect only during times of depressive episode. A state-dependent
sociation of cognitive ability has been suggested in which
riability in intelligence co-varies with depressive episode and
mission (for a comprehensive review, see Sackeim and Steif
6]). As such, subsequent investigations may benefit from
dressing the same hypotheses examining individuals with
rrent MDD in comparison to individuals in remission, and
ntrols. Increased psychological distress is an established
mptom of depression and often used in clinical diagnosis
1,32]. Goldberg [33] described distress as representing the
erall severity of depression and so it is likely that individuals
oring highly on measures of psychological distress may be more
ely to self-report the disorder, irrespective of its clinical
nificance. However, we must be mindful of the complexities
 causality; whilst it is likely that the neuroticism trait
ospectively predicts later distress and self-reported depression,
e cannot be certain that these factors are not manifestations of
e same underlying risk.
Intelligence could be a marker of system integrity [64] in which
creased intelligence circumvents negative mood biasing in
dividuals high in neuroticism that may lead to distress and
sorder [65]. Alternatively, more intelligent individuals may be
tter able to employ successful coping mechanisms during times
 distress: higher intelligence associates with increased resilience
 adversity in children [66]. Research suggests that psychosocial
ctors are associated with resilience to mood disorders [67]. Pro-
tive and psychosocial coping mechanisms may enable individu-
s decrease transient feelings of distress and to implement
tablished, effective strategies learned from previous exposure to
stress or depression [68]. This possibility is consistent with the
ding that whereas g and neuroticism interacted to associate
ith reduced psychological distress, the same interaction was not
und in clinical MDD. It would be interesting to explore
telligence’s influences on coping style [69] and subsequent
ychological distress and MDD diagnosis in future investigations.
telligence may influence the adoption of specific coping
rategies, and this could be a mediating factor in the ‘depresso-
nic’ process.
Some caveats merit comment. Different cognitive tasks were
ed to generate g across our samples. In GF:SFHS, pre-existing,
andardized measures were used, whereas UK Biobank used
spoke cognitive tasks. Further replication utilising standardised
easures would be beneficial. A second limitation is the differing
DD phenotypes used in each sample. In GS:SFHS, MDD was
termined using a semi-structured interview [47], obtaining a
bust MDD phenotype based on a standardised diagnostic tool. In
 Biobank, self-reported questionnaires were aggregated to form a
pression phenotype; this data is not as comprehensive. Although
is of benefit to have conducted an independent replication within
is study, the disparity in depression phenotypes may explain notPlease cite this article in press as: Navrady LB, et al. Intelligence and
Evidence from two large population cohorts. European Psychiatry only the difference in prevalence rates across samples, but also why
an interaction was found in UK Biobank and not GS:SFHS. Thirdly,
this investigation only examined neuroticism. Personality repre-
sents stable individual dispositions in emotional reactivity,
behavioural tendencies, and cognitive styles [22,70], which may
be moderated by intelligence in predicting mental health outcomes.
Examining such associations between all major dimensions of
personality in subsequent research is advised. As neuroticism and
MDD share genetic aetiology [2,3], causality cannot be inferred
here, although the associations reported do make a significant
contribution to the literature. Because neuroticism is a stable trait
and MDD is a disease with a given age of onset, we can use
neuroticism to predict an individual’s risk for depression, without
needing to infer causality.
In conclusion, this study fails to demonstrate that intelligence
confers protection to clinical MDD in those with high neuroticism.
However, in both samples, a modest interaction was found in
which higher intelligence appears to ameliorate the detrimental
association between neuroticism and psychological distress. It
would be useful to determine this relationship prospectively in a
sample where incident cases of MDD can be identified. An
important corollary of this work may inform risk and resilience
mechanisms in MDD. Future studies to disentangle the mecha-
nisms driving depression are an important next step in further
elucidating the aetiology of the disorder.
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